CAMDEN, Del., Sept. 23, 2026 — The latest round was led by Electric Capital, with participation from New Form Capital, Generative Ventures, Fasanara Capital, 2Square, 4th Revolution Capital, DCFGod, The Rollup and others.
Since launching in June 2025, infiniFi has generated over $9M in yield while reaching an all-time high of $180M in TVL.
In a little over a year, infiniFi has now generated more yield than the company has raised in outside capital.
From Thesis to a Live Financial System
When infiniFi emerged from stealth in February 2025 with its initial $3M pre-seed, the thesis was straightforward: bring the capital efficiency of fractional reserve banking on-chain without bringing the opacity of traditional banking with it.
Traditional banks deploy depositor capital across assets with different durations to generate returns, while keeping much of that upside themselves. infiniFi was built to automate that process transparently on-chain and return more of the economics to depositors.
What was a thesis in 2025 is a thriving ecosystem today.
infiniFi has generated more than $9M in yield while expanding across Ethereum, Arbitrum, Katana, Base and more to come, all while building an ecosystem spanning DeFi protocols and institutional asset managers.
For infiniFi, DeFi is only the beginning. With infiniFi Prime, we’re building the infrastructure to take the infiniFi system beyond crypto-native users, bringing diversified, institutionally managed private credit into Earn accounts across neobanks and consumer financial apps. With this next phase of growth, we’ll be bringing on-chain returns to off-chain users, dramatically increasing our potential market.
Partners and integrations include Ethena, Pendle, Morpho, Aave, Fasanara, FalconX, Accountable, Steakhouse Financial, Silo, Curve, Euler, and others.
“With this raise, infiniFi has secured funding to continue our mission to revolutionize how your typical person earns interest on their dollars. Through our forthcoming release of infiniFi Prime, we are expanding distribution for our offerings, while simultaneously diversifying the offerings that earn our users their returns. infiniFi stands positioned to be the leading conduit for off-chain money seeking the higher returns and greater transparency of on-chain sources and we look forward to many more years of innovation!”
– Rob Montgomery (CEO/ Founder – infiniFi)
More Yield Generated Than Capital Raised
With more than $6M raised across its pre-seed and seed rounds, infiniFi has already generated over $9M in yield, more than the company has raised in outside capital.
The new funding will accelerate a system that is already working at scale.
Building Toward TGE
The raise comes as infiniFi enters its next stage of growth, with infiniFi’s token generation event confirmed for Q4 2026.
The additional capital will support continued protocol development, new integrations, multichain expansion, and the broader rollout of infiniFi’s products as the protocol moves toward TGE.
infiniFi started with a thesis for rebuilding fractional reserve banking on-chain.
Today, with $50M+ in TVL, $9M+ in yield generated for users, and more yield generated than outside capital raised, that thesis is operating at scale.
Former Paul, Weiss partner and longtime trusted advisor to Grain joins the Firm as it advances its institutional development and expands its multi-strategy investment platform.
WASHINGTON, Sept. 23, 2026 — Grain Management, a leading global investment firm specializing in digital infrastructure, today announced the appointment of Amran Hussein as General Counsel. Based in New York, Hussein will lead the Firm’s legal and governance functions and serve as a member of and strategic advisor to Grain’s leadership team.
Amran Hussein joins Grain Management as General Counsel
A highly regarded private funds attorney, Hussein brings more than two decades of experience advising some of the world’s leading investment firms on fund formation, governance, strategic transactions, and organizational growth. Prior to joining Grain, she spent 23 years at Paul, Weiss, Rifkind, Wharton & Garrison LLP, where she advised sponsors of private investment funds across a broad range of strategies. Her work included the formation and operation of multi-investor funds, separately managed accounts, co-investment vehicles, secondary transactions, strategic joint ventures, and investment management M&A transactions.
“Amran’s appointment reflects the continued evolution of Grain as a global investment platform,” said David J. Grain, Founder and CEO of Grain. “She has been a trusted advisor to our team for many years and possesses a rare combination of legal expertise, business judgment, and strategic perspective. As Grain continues to expand its investment capabilities and institutional infrastructure, Amran will be an invaluable partner in helping us navigate our next phase of growth.”
Hussein has worked alongside Grain for more than a decade as outside counsel. Her deep familiarity with Grain’s business, culture, investment approach, and leadership team positions her to seamlessly transition into the role of General Counsel. During her career, she advised numerous emerging and established asset managers, often serving as a trusted counselor on matters extending beyond fund formation to broader business strategy, governance, and organizational development.
“After spending much of my career advising investment firms through periods of growth and transformation, I am excited to join Grain at such an important moment in its evolution,” said Amran Hussein. “Having worked closely with David and the Grain team for many years, I’ve had a unique opportunity to witness the Firm’s growth firsthand. Grain has built an exceptional platform, strengthened its organizational capabilities, and established a remarkable culture.”
Widely recognized as one of the leading attorneys in private funds, Hussein was named a Fund Formation MVP by Law360 and received the “Best in Investment Funds” distinction at the Euromoney Americas Women in Business Law Awards. She has been recognized by Chambers, The Legal 500, IFLR1000, Who’s Who Legal, and Lawdragon for her work in private equity funds and investment management. She is also an active thought leader on issues affecting the private funds industry and frequently speaks on industry panels and educational programs hosted by leading legal and professional organizations. As part of her community involvement, Hussein has served on the boards of education non-profits and has been recognized for her advocacy and mentorship efforts.
The appointment reinforces Grain’s continued investment in its leadership team and institutional infrastructure as the Firm expands its platform, broadens its investment capabilities, and pursues new growth opportunities across digital infrastructure.
About Grain Management
Founded in 2007, Grain Management is a leading global investment firm. We believe broadband and digital infrastructure are foundational to the tech-enabled transformation occurring across all industries and facets of society. Our global team of seasoned and diverse professionals share a collective passion for the power of connectivity to strengthen communities and unlock human potential for all.
We specialize in digital infrastructure and are a trusted solutions provider to the broadband and communications industry. Our unique combination of sector knowledge, experience as operators, and disciplined analytical approach guide our differentiated investment strategy across fiber networks, data centers, wireless spectrum, cell towers, as well as managed and infrastructure services. For more information, visit graingp.com.
―New in-house digital tool helps nonprofits and their stakeholders evaluate the organization’s financial health, identify areas of strength and risk, and inform strategic planning―
NEW YORK, Sept. 23, 2026 — Bernstein Private Wealth Management (Bernstein), a unit of AllianceBernstein L.P. (NYSE: AB), today announced the launch of its Nonprofit Financial Health Assessment tool, an in-house digital resource that helps nonprofits evaluate their financial health and strengthen communication with stakeholders. The tool will be available through Bernstein Advisors on September 23rd, coinciding with Bernstein’s Foundation and Institutional Advisory Forum, a two-day event convening a select group of successful nonprofit and philanthropic leaders.
The Nonprofit Financial Health Assessment tool provides nonprofits and their boards a structured way to evaluate financial health, identify strengths and risks, inform planning, and ultimately open the door to more transparency with stakeholders. It evaluates six quantitative metrics: administrative ratio, operating surplus as a percentage of assets, months of spending, primary reserve ratio, debt margin, and debt service coverage ratio, using national nonprofit benchmarks tailored to organizations of similar sizes. The tool also considers three somewhat harder to quantify factors: revenue diversification, endowment strategy, and board governance. The resulting assessment helps leaders identify strengths, vulnerabilities, and priorities – and communicate their sustainability with donors.
“This launch equips our advisors with digital tools and resources that help them better serve nonprofit and philanthropic clients,” said Rick Meyers, Executive Managing Director and Head of Client and Advisory at Bernstein. “Nonprofit leaders, their boards, and the donors investing in those organizations, are navigating legislative and economic uncertainty with limited resources and growing scrutiny. A shared framework gives advisors a clearer way to help boards evaluate trade-offs and plan with confidence.”
The Nonprofit Financial Health Assessment tool further complements Bernstein’s existing Reserves Analysis Tool, which helps nonprofit boards evaluate appropriate cash reserve levels based on revenue, spending, timing, and borrowing risks. Together, they offer boards a fuller view of financial resilience: the Reserves Analysis Tool supports forward-looking reserve decisions, while the Nonprofit Financial Health Assessment offers a broader diagnostic across operations, liquidity, debt management, revenue diversification, endowment readiness, and board governance.
“The nonprofit and philanthropic sector is becoming increasingly complex, and leaders are looking for sophisticated but simple analytical tools to inform decision-making,” said Marisa Swystun, Senior National Director of Bernstein’s Foundation and Institutional Advisory practice. “This resource gives nonprofits, their donors, and Bernstein Advisors a clearer, shared view of long-term financial sustainability.”
This launch is informed by Bernstein’s latest research, Measuring the Financial Health of Mid-Sized Nonprofits, conducted with Indiana University’s Lilly Family School of Philanthropy. The research analyzed data from more than 800,000 IRS Form 990s, reviewed existing academic literature, and conducted seven in-depth case studies to identify best practices. The result is benchmarked nonprofit reporting that serves as a strong evaluation and stewardship resource.
For nearly 60 years, Bernstein has taken a holistic approach to advising nonprofits, private foundations, philanthropists and board leaders on investment management, planning, and specific needs. Its Foundation and Institutional Advisory team supports more than 1,000 organizations nationwide with expertise, research, and custom tools for fundraising, governance, operations, and long-term planning. Bernstein manages $167 billion in assets under management as of June 30, 2026.
About Bernstein Private Wealth Management Bernstein Private Wealth Management (Bernstein) advises ultrahigh- and high-net-worth clients on planning and living with the complexities that come with significant wealth. Bernstein is distinguished among major wealth managers for its expertise in navigating life transitions through a holistic approach. A flexible process paired with innovative research, sophisticated modeling, and cutting-edge investment solutions also set Bernstein apart. It operates as a business unit of AllianceBernstein (AB), a leading global investment management firm that offers diversified investment services to institutional investors, individuals, and private wealth clients with over $909 billion in assets under management as of July 31, 2026. AB is a subsidiary of Equitable Holdings, Inc. (EQH), a leading financial services holding company that comprises well-established and complementary businesses.
Blockchain Capital leads strategic investment, bringing total funding raised since its 2021 founding to over $65 million
SÃO PAULO, Sept. 23, 2026 — NG.CASH, a Brazilian fintech rooted in the creator economy and built for a new generation’s relationship with money, today announced a $15 million strategic investment led by Blockchain Capital, bringing the company’s total funding raised since its 2021 founding to over $65 million.
NG.CASH, in 2021, started as an offshoot of a YouTube channel with 10 million subscribers, which has since grown to 20 million, and has grown into a platform serving more than 10 million users. The round comes as leading venture firms increasingly look to de-risk from an oversaturated U.S. market by backing category-defining companies in large international markets like Brazil.
“Millions of young Brazilians have grown up without a financial platform built for the way they actually live and bank,” said Mario Augusto Sá, NG.CASH’s CEO and Co-founder. “Blockchain Capital’s investment confirms NG.CASH is becoming that platform, the company building what comes next as money itself evolves in Brazil.”
NG.CASH’s core users come from middle- and lower-income households across Brazil, many from families where parents have never had a bank account of their own. For a lot of these users, NG.CASH is the first financial account anyone in the family has opened.
The company holds two Central Bank of Brazil licenses, a direct credit society license and a payment institution license. It has a Virtual Asset Service Provider (VASP) license application in process, giving it a regulatory foundation few can match. NG.CASH has grown to more than 10 million accounts since its 2021 founding, with billions of dollars already transacted on the platform. Credit products including Crédito CLT and Pix Crédito are driving that growth, and the company is targeting BRL 1 billion (nearly $200M USD) in credit originated by 2027.
“We’ve spent years looking outside the U.S. for the next generation of category-defining fintech companies,” said Kinjal Shah, General Partner at Blockchain Capital. “Brazil is exactly the kind of market we believe will produce them. NG.CASH has already proven it can build and scale a business young Brazilians actually use, and that’s why exactly why we wanted to invest.”
NG.CASH’s own history as a mass-market distributor, born from a YouTube channel and grown into a large financial platform, positions it to become one of the first movers on stablecoin and crypto adoption at scale in Brazil.
For more information about NG.CASH, visit www.ng.cash.
About NG.CASH
NG.CASH is a Brazilian fintech building the future of financial experiences through innovation, technology, and digital culture. Founded in 2021, the company was created to transform how a new generation connects with money by combining intuitive design, world-class technology, and a deeply digital-native approach. Originally rooted in the creator economy, NG.CASH has evolved into a robust financial ecosystem that supports users from their first steps toward financial independence to more advanced solutions such as investments and credit, reinforcing its position at the forefront of the next era of digital finance in Brazil.
Selected from 158 applicants, ORION Security is recognized as a cybersecurity innovator shaping what comes next
NEW YORK, Sept. 23, 2026 — ORION Security, the agentic data loss prevention (DLP) platform, today announced it has been named a 2026 SINET16 Honoree, one of just 16 companies selected from 158 applicants across 10 countries.
The 2026 SINET16 were chosen through a fiercely competitive selection process led by more than 100 industry experts, including CISOs from industry-leading enterprises. In announcing this year’s honorees, SINET called them “the most promising early-stage and emerging cybersecurity companies shaping what comes next.”
SINET connects CISOs, risk executives, and investors with early-stage companies driving cutting-edge cybersecurity solutions. Its annual SINET16 program recognizes companies developing innovative approaches to some of cybersecurity’s most pressing challenges.
Leading those challenges, the explosion of AI, SaaS, and cloud applications has changed how sensitive data moves through the enterprise, exposing the limits of legacy DLP tooling built around predefined rules and individual control points. ORION Security takes a fundamentally different approach and is built around data movement, context, and user intent.
“Being named a SINET16 Honoree is especially meaningful, with votes coming from cyber professionals and ORION Security customers who understand what enterprise security teams are up against,” said Nitay Milner, Co-Founder and CEO of ORION Security. “Data security is at the forefront of this change, with companies requiring visibility and control of data in motion. Data loss prevention is undergoing a renaissance, and ORION Security is leading the charge.”
The ORION agentic DLP platform brings together continuous data lineage, context-aware classification, identity, environment, and user intent across endpoints, browsers, AI tools, SaaS, and email. Where some DLP tools use AI only to classify data or triage alerts, ORION uses AI to reason over the risk of the movement itself, detecting threats without requiring security teams to anticipate every threat.
The SINET16 recognition follows a period of rapid growth for ORION. In February 2026, the company raised a $32 million Series A led by Norwest Venture Partners, with participation from IBM Ventures and existing investors, bringing total funding to $38 million.
ORION Security is the agentic data loss prevention platform. Using proprietary AI agents that analyze data in motion and detect real indicators of data loss risk, ORION Security delivers context-aware verdicts across every channel, including endpoints, browsers, SaaS, email, and agentic AI workflows, without rules, policies, or manual tuning. The result is dramatically reduced overhead and real incidents stopped before they become data leaks.
Enterprise information security teams get total visibility and control, answers instead of false positives, and data loss prevention (DLP) that continuously learns and evolves with the business. For more information about ORION Security, visit orionsec.io.
About SINET
SINET’s mission is to advance innovation to defeat global cybersecurity threats. The organization connects CISOs, risk executives, and investors with early-stage and emerging companies driving cutting-edge cybersecurity solutions. By facilitating transparent dialogue, earning trust, and building relationships, SINET empowers its network to build a safer, more resilient digital future.
Investment announced alongside Relevance Ventures’ sponsorship and participation at NAFOA’s 2026 Fall Finance & Tribal Economies Conference
NASHVILLE, Tenn. and SANTA FE, N.M., Sept. 23, 2026 — Relevance Ventures (“Relevance”), one of the nation’s only independently owned Native American venture capital firms, today announced that it has led a multimillion Series B financing in Aqua Medical, Inc. (“Aqua”), a clinical-stage medical technology company with a minimally invasive endoscopic approach to treating Type 2 diabetes. The investment was announced as Relevance participates as a sponsor and exhibitor at the 2026 NAFOA Fall Finance & Tribal Economies Conference in Santa Fe, where Tribal leaders, investors and financial professionals are convening around economic growth, capital access and sovereignty.
“Type 2 diabetes represents exactly the kind of challenge Relevance Ventures exists to combat. This is a significant human need with an opportunity for innovation to materially change outcomes and people’s lives,” said Dean Newton, Chairman and General Partner of Relevance Ventures. “Aqua is pursuing a fundamentally different approach to a disease that affects Native Americans at twice the national average, while claiming hundreds of millions of sufferers globally. We believe that combination of potential impact and scale is where some of the most compelling investment opportunities are created.”
Type 2 diabetes affects approximately 589 million people worldwide, and contributes to more than $1 trillion in annual healthcare expenditures globally, including approximately $327 billion in the United States, according to figures cited by Aqua Medical. To address this, Aqua Medical deploys an investigational Proximal Intestinal Mucosal Ablation (PIMA) procedure using a proprietary radiofrequency vapor ablation platform.
“Rather than relying solely on pharmaceutical management or more invasive surgical interventions, Aqua is building a minimally invasive, device-based approach to addressing metabolic disease,” explained Bob Haggerty, President and CEO of Aqua Medical. “Proceeds from this financing will support the completion of our ongoing U.S. RESTORE-1 pilot study and preparations for a planned U.S. pivotal trial, subject to regulatory authorization.”
The RESTORE-1 study is currently evaluating PIMA at participating U.S. clinical sites under an FDA-approved Investigational Device Exemption. The product is FDA-cleared for the coagulation and ablation of bleeding and non-bleeding sites in the gastrointestinal tract. Its use for type 2 diabetes is currently under clinical investigation.
“Our investment philosophy is aimed at solving meaningful problems while creating enduring businesses,” said Cameron Newton, Managing Partner of Relevance Ventures. “That means backing companies across personal health, digital health, community health and financial health that address systemic challenges while pursuing market-rate financial outcomes. Aqua fits squarely within that framework.”
It’s fitting that Relevance announced this investment while co-sponsoring and attending NAFOA, highlighting how Native -owned capital can support the development of treatments for Native health challenges. “NAFOA is an important gathering because it brings together leaders thinking seriously about capital, sovereignty and long-term economic strength,” added Kelly Holmes, Venture Partner & Tribal Ambassador of Relevance Ventures. “For us, announcing an investment like Aqua in that environment reinforces that Native participation in the capital markets brings real benefits to Indian Country, while not being limited to one sector or one geography.”
Additionally, as part of the financing deal, Dean Newton has joined Aqua Medical’s Board of Directors. This furthers the confidence and alignment between Relevance Ventures and Aqua Medical, committing to be not just a capital provider, but a true partner for companies creating lasting health outcomes.
About Relevance Ventures
Relevance Ventures is a Native American, privately owned and operated venture capital firm with more than $100 million under management. The firm invests in high-growth companies across personal health, community health, digital health, and financial health. Founded by Cameron and Dean Newton, Relevance is headquartered in Nashville, Tennessee, with an expanding presence in multiple U.S. growth markets. The Newtons are members of the Patawomeck Tribe of Virginia. For more information, visit www.Relevanceventures.com.
About Aqua Medical
Aqua Medical is a clinical-stage medical technology company advancing a minimally invasive, through-the-working-channel-of-the-scope technology to address Type 2 diabetes. Using its proprietary radiofrequency vapor ablation (RFVA) system for the Proximal Intestinal Mucosal Ablation (PIMA) procedure, the company aims to deliver a scalable, device-based approach intended to address mechanisms associated with Type 2 diabetes and potentially improve metabolic outcomes.
The RFVA system is FDA-cleared for marketing for its indicated use in the gastrointestinal tract. Use of the RFVA system for the PIMA procedure is investigational. The safety and effectiveness of the RFVA system for the PIMA procedure have not yet been established.
Forward-Looking Statements
This press release contains forward-looking statements regarding Aqua Medical’s investigational technology, clinical development activities, and future expectations. Actual results may differ materially. Aqua Medical encourages patients to reach out to the company or their physician to explore the opportunity to be treated with this new technology.
NEW YORK, Sept. 23, 2026 — Invest Qatar, the Investment Promotion Agency of Qatar, today announced a strategic engagement with Aurion Capital, a global investment group, and LG NOVA, the Silicon Valley–based North America Innovation Centre for LG Electronics. This engagement aims to explore opportunities to scale regional investments and support the commercialisation of emerging technologies and business ventures to strengthen Qatar’s position as a regional hub for entrepreneurship and high-growth ventures.
Invest Qatar, the Investment Promotion Agency of Qatar, today announced a strategic engagement with Aurion Capital, a global investment group, and LG NOVA, the Silicon Valley–based North America Innovation Centre for LG Electronics.
Announced during the special edition of the Qatar Economic Forum Powered by Bloomberg, held on the sidelines of the 2026 United Nations General Assembly in New York, a new Memorandum of Understanding among the parties establishes a framework to explore collaboration across shared priorities, including targeted innovation programmes and scale-up support in high-growth sectors such as artificial intelligence (AI), digital health, financial technologies (FinTech), digital infrastructure, sports, media and entertainment.
Additionally, a new hub in Qatar Science & Technology Park (QSTP), serving as a regional platform for LG NOVA-affiliated technologies and ventures, is anticipated to support the expansion of advanced technology solutions, foster collaboration between innovators, investors and industry partners and enable high-potential companies to scale across the Gulf Cooperation Council (GCC) and the Middle East and North Africa (MENA) region.
Sheikh Ali bin Alwaleed Al-Thani, CEO, Invest Qatar, said: “This strategic collaboration reflects the multilateral strength of Qatar’s value proposition. Our world-class research and development (R&D) ecosystem, robust talent pipeline and pro-business regulatory environment position Qatar as an ideal platform to test, deploy and commercialise advanced technologies. Coupled with our strategic location and future-ready digital infrastructure, Qatar offers international investors a gateway to the MENA region and a natural pathway for sustainable regional expansion.”
“At Aurion Capital, we believe the future of innovation will be built through stronger connections between global markets and ecosystems,” stated Ali Diallo, Founding CEO of Aurion Capital. Our mission is to mobilize capital and strategic resources across America, Asia, the Gulf and emerging markets to create enduring economic value and accelerate the growth of transformative technologies. Qatar’s ambition, investment ecosystem, and strategic position between East and West make it one of the world’s most compelling destinations for innovation-led growth. Together with Invest Qatar and LG NOVA, we look forward to building a platform that helps scale world-class companies, unlock new investment opportunities, and strengthen the flow of innovation across regions.”
“The next technology evolution, driven by AI, is creating extensive opportunities for new business and industry growth, across all sectors. By exploring these new opportunities with Invest Qatar and Aurion Capital we’re strengthening our capabilities to build meaningful businesses that will shape our future,” stated Sokwoo Rhee, EVP of Corporate Innovation for LG Electronics and Head of LG NOVA. “Our innovation process brings collaborators together to create impactful change, and by working with Invest Qatar, spearheaded by Aurion Capital, we’ll be able to connect our ecosystems across the world.”
Through this engagement, Invest Qatar will work closely with Aurion Capital and LG NOVA to plan and design innovation-led programmes in collaboration with key national stakeholders. It will also provide tailored facilitation and advisory support to Aurion Capital and LG NOVA-affiliated companies seeking to establish or expand operations in Qatar.
Aurion Capital and LG NOVA may explore potential deployment of their global innovation capabilities and investment platforms to strengthen technology testing, localisation and commercialisation capabilities within Qatar.
This objectives of this collaboration further cement Qatar’s position as a regional hub for research, development and innovation in advanced technologies, attracting high-quality private-sector investment in priority sectors identified under NDS3 and contributing to long-term economic diversification.
About Invest Qatar
The Investment Promotion Agency Qatar (Invest Qatar) is responsible for overseeing investment promotion activities, aimed at attracting foreign direct investment to Qatar. Established in 2019, Invest Qatar’s mission is to accelerate Qatar’s economic diversification and global competitiveness by proactively attracting targeted investment, developing priority economic clusters, and delivering an exceptional end-to-end investor experience.
As the gateway to investment solutions, Invest Qatar connects investors to an integrated ecosystem of business and licensing platforms. The Agency partners with investors throughout their journey, from exploration and setup to expansion, supporting their long-term growth by providing comprehensive insights into Qatar’s business landscape, sector-specific market knowledge and tailored investment facilitation.
LG NOVA is a venture-building platform focused on delivering new experiences powered by AI, built from collaboration with innovators across the ecosystem. LG NOVA is based in Santa Clara, Calif, with a branch office in Morgantown, WVa. The center’s mission is to fuel innovation for LG and its partners by creating and launching new AI-first ventures to become the next growth engine for LG. Learn more about LG NOVA at www.lgnova.com.
LG NOVA is the North America Innovation Center for LG Electronics, a global innovator in technology and consumer electronics with a presence in almost every country and an international workforce of more than 75,000. LG is a leading manufacturer of consumer and commercial products ranging from TVs, home appliances, air solutions, monitors and automotive components. LG Electronics is a part of LG Corporation, South Korea’s fourth largest industrial conglomerate. Learn more about LG Electronics at www.lg.com.
About Aurion Capital
Aurion Capital is an American investment group focused on scaling high-growth companies, strategic industries, and critical infrastructure across the United States and global markets. The Group operates a multi-strategy investment strategy, deploying capital and resources across venture capital, private equity infrastructure, and venture studio innovation through its specialized business units.
Aurion integrates investment management, strategic collaborations, venture building, and public-private partnerships to connect capital, technology, industry, and global markets. Its investment platforms span key sectors including TMT (Technology, Media, and Telecom), healthcare, sports and entertainment, critical minerals, and energy and power with a pipeline of industrial projects representing more than 2 GW of generation capacity.Aurion Capital is the parent company of NovaWave Capital, a Silicon Valley venture capital firm focused on artificial intelligence, with $100 million in assets under management, that is supported by corporate investors and government partners, including LG Electronics and the U.S. states of West Virginia, Arizona, and Nevada. Aurion Capital also serves as General Partner to BYL Ventures, a Los Angeles-based venture capital fund with $ 70 million in assets under management.
Oversubscribed Series C led by S32 with backing from NVIDIA and others
Funding will advance a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and expand pharmaceutical partnerships
The company has demonstrated strong preclinical results across multiple modalities and disease areas
LONDON and BOSTON, Sept. 23, 2026 — Basecamp Research, a frontier AI company developing AI-designed medicines, today announced a $140M Series C financing to train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.
Basecamp’s ambition is to develop cures for diseases that remain incurable by designing medicines that reprogram the body to repair itself. The company combines frontier AI models trained on proprietary biological data with technology for writing DNA sequences into cells.
Basecamp Research team and biodiversity data partners in Malawi
Basecamp Research translation lab in Kendall Square, Cambridge, MA
“We believe the future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how,” said Glen Gowers, co-founder and CEO of Basecamp Research. “AI-based approaches promise to change what’s possible for patients who currently have few alternatives. This funding brings this technology closer to those who need it most.”
The oversubscribed round was led by S32, with participation from Anthropic’s Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI and True Ventures.
Additional investment comes from senior leaders from across pharma, biotech, and global industry, including André Hoffmann, Vice-Chairman of Roche, who said: “The biotechnology revolution that began fifty years ago transformed how we make medicines. Personalised, AI-designed therapeutics represent the next transformation of that journey. Basecamp Research has built the full platform to deliver it, from biological data to trained models to designed therapies. This will be key in helping the industry to continue to innovate.”
Applying EDEN to develop new therapies
Basecamp Research is applying EDEN, its biological foundation model, to in vivo cell therapy – reprogramming a patient’s cells inside the body. Today’s cell therapies are limited both in the complexity of what they can deliver and by a manufacturing process that costs hundreds of thousands of dollars per patient.
By pairing EDEN’s ability to design long and complex DNA sequences with large serine recombinases that can precisely integrate them into the genome, Basecamp’s platform aims to underpin the future of cell therapies, making them more sophisticated, more customisable and simpler to administer. This has the potential to transform how we treat cancer, autoimmune disease, and more.
The company has demonstrated strong preclinical results across multiple modalities and disease areas. To expand its pharmaceutical partnerships, Basecamp has appointed Richard Pearce, formerly of Biogen, as Chief Business Officer.
Andy Conrad, General Partner at S32 and former CEO of Google’s Verily, who joins the Board of Directors, said: “AI is opening up new possibilities across every part of society, but perhaps nowhere is the potential more meaningful than in human health. The ability to combine AI, biological data and scientific insight could transform how we understand disease, discover medicines and ultimately improve and extend people’s lives. Basecamp Research is building an important technology platform at the center of that opportunity.”
The AI and data powering Basecamp Research’s therapies
At the centre of Basecamp Research’s AI platform is the Trillion Gene Atlas, the world’s largest proprietary biological AI training dataset. Built with partners including NVIDIA, Anthropic, PacBio and Ultima Genomics, the Atlas draws on biological data collected through access and benefit-sharing partnerships in more than 30 countries across all seven continents.
Trained on this data, the company’s EDEN models recognise patterns across a huge breadth of previously unseen biology. Unlike AI systems developed for a single scientific task, EDEN models aim to deliver a universal understanding of how DNA works across all of life.
This means that the models can generate potential therapeutic candidates directly from information about a disease, an approach already demonstrated through Basecamp’s collaboration with Anthropic on Claude Science. The EDEN models’ capabilities include designing cell and gene therapies, enzymes and peptides.
About Basecamp Research
Basecamp Research trains frontier AI models for therapeutic design. The EDEN models are trained on the Trillion Gene Atlas, the world’s largest proprietary genomic dataset, collected through partnerships in more than 30 countries worldwide. Its pipeline of EDEN-designed therapeutics, beginning with in vivo cell therapy, is advancing towards clinical development. Basecamp Research is headquartered in London with offices and labs in Cambridge, MA.
Two GenesisL1 Insights publications pair a Renaissance-scale case for public scientific memory with block-pinned stake evidence at block 13,690,968.
SHERIDAN, Wyo., Sept. 23, 2026 — GenesisL1, a Layer 1 for decentralized science and verifiable AI, today announced two Insights publications and invited universities, biobanks, research hospitals, biotechnology companies and public agencies to help operate public scientific infrastructure.
GenesisL1 presents public scientific infrastructure as durable institutional memory connecting universities, biobanks, archives, public authorities and independently operated nodes.
Block-pinned GenesisL1 evidence at height 13,690,968 records 33 active validators, 27.38% top-five voting power, 25,555,236.79 L1 bonded and 1,402 active delegator addresses.
GenesisL1 launched with no token sale, private round, insider allocation or private unlock schedule; the bootstrap distributor retained nothing after the public one-to-one transition. That alone does not prove decentralization, but it removes insider vesting and reserved claims from the protocol’s origin. Public patronage runs through the community pool and on-chain governance, not a founding cap table.
“GenesisL1 and the Next Verifiable Renaissance” argues that presses, libraries, universities and scientific societies transformed discovery by letting knowledge outlive its author, patron or institution. As AI makes science machine-executable, GenesisL1 proposes a public layer preserving the identity, provenance, authorization and computational history of scientific objects while protected data stays local.
The companion analysis, “GenesisL1 Stake Distribution and Decentralization,” tests whether distributed stewardship can be measured rather than asserted. It preserves raw responses, tables and 158 SHA-256-listed files. GenesisL1 recorded 33 active validators, 25,555,236.79 L1 bonded and 1,402 delegator addresses; the largest validator held 9.27% of voting power and the top five 27.38%. Since July the active set has grown from 20 to 33, top-five share has fallen from 51.07% and the two-thirds coefficient has widened from eight to 18. The newest interval is reported without selective framing: HHI improved while the largest-validator share rose from its previous low.
“Scientific infrastructure should not ask institutions to rent access to their own memory,” said Mikhail Fedorov, founder of GenesisL1. “Run a validator, preserve an archive node, reproduce the evidence, or define one bounded workflow another institution can inspect.”
L1 coin is the native resource for fees, staking, governance and settlement, not equity, a revenue claim or a promise of return.
About GenesisL1 GenesisL1 is a public, permissionless EVM-compatible Layer 1 for scientific data, deterministic models, programmable rights and community governance. Ledger verification establishes provenance and authorization, not biomedical validity or clinical safety. Decentralized Science Labs LLC and Bioinformatics LLC contribute research and software but do not own or control the network.
Media Contact Mikhail Fedorov, Founder, GenesisL1 +1 207-987-0880 [email protected]
